首页> 外文期刊>Infant, child & adolescent nutrition. >Senate Bill 311: Providing Health Care Coverage of Medically Necessary Foods
【24h】

Senate Bill 311: Providing Health Care Coverage of Medically Necessary Foods

机译:参议院第311号法案:提供医疗必需食品的医疗保健

获取原文
       

摘要

Inborn errors of metabolism (IEMs) are heritable disorders in the biochemical processes of metabolism that occur in approximately 1 in every 1500 live births. The lifelong disorder is treatable through the use of medical foods, specially formulated foods that contain the nutritional content, and dietary restrictions customized to each type of disorder. Without treatment, the buildup of toxic substances in the blood would lead to progressive brain damage, mental retardation, and death. There are approximately 700 different types of IEMs, but today, only 30 are detectable through newborn screening. Each state has mandates to screen for such disorders at birth; however, there are no federal mandates to provide treatment for IEMs. Some states require health insurance companies to cover the costs of these expensive medical foods as treatment, but coverage is insufficient and often expires at adolescence. Senate Bill 311 (S.311), the Medical Foods Equity Act of 2011, proposes to provide coverage of medically necessary foods and other treatment costs under federal health programs and private health insurance. This bill would create uniform access to treatment for all individuals diagnosed with an IEM and reduce the financial burden on families. S.311 would also create a cost–benefit effect in which continuous treatment of IEMs would diminish the risks of developing mental retardation, a disorder that costs significantly more to treat through federal and private health care.
机译:代谢先天性错误(IEM)是代谢生化过程中的遗传性疾病,每1500例活产中大约发生1例。可以通过使用医疗食品,含有营养成分的特殊配方食品以及针对每种疾病的饮食限制来治疗终生疾病。如果不进行治疗,血液中有毒物质的积累将导致进行性脑损伤,智力低下和死亡。大约有700种不同类型的IEM,但如今,通过新生儿筛查仅可检测到30种。每个州都有在出生时筛查此类疾病的授权;但是,没有联邦命令为IEM提供治疗。一些州要求健康保险公司负担这些昂贵的医疗食品的治疗费用,但承保范围不足,而且往往在青春期就到期。参议院第311号法案(S.311)是2011年的《医疗食品公平法》,提议根据联邦卫生计划和私人健康保险的规定,提供医疗必需食品和其他治疗费用的承保范围。该法案将为所有被诊断为IEM的个人提供统一的治疗机会,并减轻家庭的经济负担。 S.311还将产生成本效益效应,在这种效应中,对IEM进行持续治疗将降低发展为智力低下的风险,这种疾病通过联邦和私人医疗保健的治疗费用要高得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号